Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS)

Historical Holders from Q2 2022 to Q3 2025

Symbol
RGLS on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
66,505,186
All holders as of 30 Sep 2025
Q3 2025
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 3.9% $4,637,853 2,696,426 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
Point72 Asset Management, L.P. 0.3% -93% $1,897,906 -$28,982,448 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025

Institutional Holders of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 0
2025 Q2 0 $0 -$105,305,672 $8.16 0
2025 Q1 53,596,381 $105,311,490 +$3,105,905 $1.75 74
2024 Q4 53,508,570 $84,543,322 -$5,126,515 $1.58 68
2024 Q3 56,729,933 $89,080,213 +$3,279,940 $1.57 71
2024 Q2 54,841,321 $97,892,350 +$13,517,965 $1.78 63
2024 Q1 45,620,114 $128,657,473 +$102,997,296 $2.88 44
2023 Q4 9,168,367 $11,735,268 +$40,059 $1.28 24
2023 Q3 8,956,428 $12,343,312 +$1,002,811 $1.37 23
2023 Q2 8,228,751 $12,096,772 +$2,407,893 $1.47 22
2023 Q1 6,598,665 $5,593,075 -$77,445 $0.8475 23
2022 Q4 6,670,888 $9,138,385 -$4,967 $1.37 22
2022 Q3 6,668,921 $11,336,000 +$3,421,938 $1.70 21
2022 Q2 4,621,632 $9,564,000 +$9,563,990 $2.06 22